Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Trial of ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transplantation (UCBT) in Patients With Inborn Errors of Metabolism

NCT00654433 is registered in ClinicalTrials.gov with Aldagen as lead sponsor.

NCT NCT00654433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00654433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Trial of ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transplantation (UCBT) in Patients With Inborn Errors of Metabolism
Lead sponsor
Aldagen
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2008
Completion date
November 30, 2011
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

inborn errors of metabolism, inherited metabolic diseases, lysosomal storage disorders, mucopolysaccharidosis, peroxisomal storage diseases